Enhancement of carvedilol solubility by solid dispersion technique using cyclodextrins, water soluble polymers and hydroxyl acid.
Aim of the present work is to enhance aqueous solubility of carvedilol (CV) by solid dispersion technique using wide variety of carriers such as: β-cyclodextrin (βCD), hydroxypropyl-β-cyclodextrin (HPβCD), tartaric acid (TA), polyvinyl pyrrolidone K-30 (PVP K-30) and poloxamer-407 (PLX-407). Various products of 'CV-solid dispersion' had been studied extensively in various pH conditions to check enhancement of solubility and dissolution characteristics of carvedilol. Any physical change upon interaction between CV and carriers was confirmed by instrumental analysis: XRD, DSC, FTIR and SEM. Negative change of Gibb's free energy and complexation constants (Kc, 75-240M(-1), for cyclodextrins and 1111-20,365M(-1), for PVP K-30 and PLX-407) were the evidence of stable nature of the binding between CV and carriers. 'Solubility enhancement factor' of ionized-CV was found high enough (340 times) with HPβCD in presence of TA. TA increases the binding efficiency of cyclodextrin and changing the pH of microenvironment in dissolution medium. In addition, ionization process was used to increase the apparent intrinsic solubility of drug. In vitro, dissolution time of CV was remarkably reduced in the solid dispersion system compared to that of pure drug. This may be attributed to increased wettability, dispersing ability and transformation of crystalline state of drug to amorphous one.
Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, West Bengal, India. Electronic address: yuvaju@gmail.com.
K
K
Yuvaraja
Department of Pharmaceutical Technology, Jadavpur University, Kolkata 700032, West Bengal, India.
Jasmina
J
Khanam
D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage / Q000737:chemistry; D002227:Carbazoles / Q000008:administration & dosage / Q000737:chemistry*; D000077261:Carvedilol; D002626:Chemistry, Pharmaceutical; D003460:Crystallization; D003505:Cyclodextrins / Q000737:chemistry*; D004337:Drug Carriers / Q000737:chemistry; D005079:Excipients / Q000737:chemistry; D006863:Hydrogen-Ion Concentration; D011108:Polymers / Q000737:chemistry*; D011412:Propanolamines / Q000008:administration & dosage / Q000737:chemistry*; D012995:Solubility; D013644:Tartrates / Q000737:chemistry*; D014867:Water / Q000737:chemistry
D000319:Adrenergic beta-Antagonists; D002227:Carbazoles; D003505:Cyclodextrins; D004337:Drug Carriers; D005079:Excipients; D011108:Polymers; D011412:Propanolamines; D013644:Tartrates; D014867:Water; D000077261:Carvedilol; C029768:tartaric acid
Carvedilol; Cyclodextrin; Dissolution enhancement; Ionization process; Tartaric acid; Water soluble polymer